Company intelligence / Profile preview
ChromoLogic
Monrovia, California, USAchromologic.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Commercial
01
Overview
ChromoLogic develops innovative biomedical solutions with a focus on point-of-care diagnostics, drug delivery systems, wound care, infectious disease treatment (including malaria), and telehealth. They have developed multiple R&D programs within the regenerative manufacturing industry and are advancing novel cell therapy platforms for broad applications from infectious diseases to cancer. No published clinical trial results or marketed products were identified
- Therapeutic areas
- OtherOncologyDermatologyInfectious Diseases
- Modalities
- Cell therapyDrug delivery device
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
BioFabUSA/ARMICollaborations with medical manufacturersAcademic institutionsGovernment agencies
Beyond the preview
Go deeper on ChromoLogic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ChromoLogic.